Health Library
March 3, 2026
Question on this topic? Get an instant answer from August.
• Gabapentin is not a standard arthritis treatment and is not recommended in current guidelines for osteoarthritis or rheumatoid arthritis, but doctors sometimes prescribe it off-label when arthritis pain has a nerve related (neuropathic) component.
• A clinical trial found that gabapentin reduced knee osteoarthritis pain significantly better than acetaminophen over 12 weeks, though its effects built gradually and peaked around third month.
• The main drawbacks are side effects like drowsiness and dizziness, a modest increase in fracture risk for arthritis patients, and mixed cost effectiveness data that suggests it may not offer clear value for most people with typical joint pain.
Gabapentin was originally designed to treat seizures and nerve pain conditions like postherpetic neuralgia and diabetic neuropathy. It works by calming overactive nerve signals in central nervous system. That is very different from how traditional arthritis medications like NSAIDs or corticosteroids work, which target inflammation directly at joint.
So why does it come up in arthritis conversations? Because not all arthritis pain is purely inflammatory. Some people with osteoarthritis or rheumatoid arthritis develop what researchers call "nociplastic pain." This is pain that comes from a sensitized nervous system rather than ongoing tissue damage. In these cases, brain and spinal cord amplify pain signals even when inflammation is under control.
When standard treatments like anti-inflammatory drugs and physical therapy are not providing enough relief, a doctor might consider gabapentin to address that nerve-level component of pain.
The evidence is mixed, and that is important to understand upfront.
One randomized clinical trial compared gabapentin (300 mg twice daily), duloxetine (30 mg twice daily), and acetaminophen (1000 mg twice daily) in 150 patients with moderate to severe knee osteoarthritis over 12 weeks. Both gabapentin and duloxetine performed significantly better than acetaminophen at reducing pain and improving function. However, gabapentin worked more gradually. Its best results showed up at end of third month, while duloxetine started working within first few weeks.
On other hand, a cost-effectiveness analysis published by researchers at Brigham and Women's Hospital used modeling to evaluate whether adding gabapentin to standard knee osteoarthritis care made sense from a value perspective. Their conclusion was that usual care without gabapentin led to better outcomes and lower costs, even when targeting gabapentin specifically to patients who screened positive for nociplastic pain. The side effect profile was a major factor in that finding.
For rheumatoid arthritis specifically, picture is even less clear. A Cochrane review found very limited evidence on gabapentin for RA pain, and no major trials have been designed to test it in that population.
Gabapentin is more likely to help when your arthritis pain includes features that go beyond typical joint inflammation. These features can include pain that feels burning, tingling, or electric rather than just dull and achy. Pain that spreads beyond affected joint to nearby areas. Sensitivity to touch or pressure that seems out of proportion to level of joint damage. Pain that persists even when your inflammation markers (like CRP or ESR) are well controlled.
If your pain is mainly mechanical, meaning it gets worse with movement and better with rest and responds well to anti-inflammatory medications, gabapentin is less likely to add much benefit.
Gabapentin's side effect profile is a big part of why it is not a first-line arthritis treatment. The most common issue is drowsiness, which affects a significant percentage of users. Dizziness, fatigue, and difficulty concentrating are also common, especially when starting medication or increasing dose.
For people with arthritis, there is an additional concern. A large study using English primary care data found that patients with inflammatory arthritis who were currently taking gabapentinoids had a 36 percent higher odds of fractures compared to those who had used medication in past. Since arthritis patients already have an elevated fracture risk from reduced mobility and sometimes from corticosteroid use, this finding matters.
Weight gain is another side effect some people experience. For those with knee or hip osteoarthritis, added weight can increase mechanical stress on already damaged joints.
For most people with arthritis, first-line options remain NSAIDs (like ibuprofen or naproxen), acetaminophen, physical therapy, and in some cases corticosteroid injections. These have far more evidence behind them for joint pain specifically.
Duloxetine is an antidepressant that has been studied more extensively for osteoarthritis pain and is conditionally recommended in some guidelines for knee OA when standard treatments are not enough. It may be a better choice than gabapentin when nerve sensitization is contributing to pain.
Gabapentin tends to be most useful as an add-on medication rather than a replacement for standard arthritis care. If your doctor has tried usual approaches and you are still dealing with pain that has neuropathic features, gabapentin might be worth discussing. It is also sometimes used for other types of pain beyond its original approved indications.
Gabapentin is not a go-to treatment for arthritis pain, and current guidelines do not recommend it for routine use in osteoarthritis or rheumatoid arthritis. However, it can play a supporting role when arthritis pain has a nerve sensitization component that is not responding to standard anti inflammatory treatments. The evidence shows it can reduce pain in some people, but side effects like drowsiness, fracture risk, and weight gain need to be weighed carefully. If you think your arthritis pain might have a neuropathic element, bring it up with your doctor to see if gabapentin makes sense as part of your overall plan.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.